STAT+: Lawmakers want U.S. biotech to outcompete China
Want to stay on top of the science and politics driving biotech today?
- Continue to STAT+ to read the full story….
- Merck enlists Isomorphic for mystery target Merck already has an oncology target it considers strategically important — and a trove of wet lab data from its own work on it.
- With Heidi Overton out, who’s gonna lead the FDA?
Now, STAT’s Katherine MacPhail writes exclusively, it’s bringing in Isomorphic Labs to see whether the DeepMind spinoff’s AI models can use those data to find promising small molecules faster.
Sign up to get our biotech newsletter in your inbox.
How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →